Outcome Of Younger Adults With Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (All) In First Relapse: A Graall Study

Alexandre Desjonqueres, Patrice Chevallier, Xavier Thomas, Françoise Huguet,Thibault Leguay,Marc Bernard, Jacques-Olivier Bay,Emmanuelle Tavernier,Aude Charbonnier,Françoise Isnard,Mathilde Hunault,Pascal Turlure,Marc Renaud,Jean-Noël Bastie,Chantal Himberlin,Stéphane Leprêtre,Bruno Lioure,Véronique Lhéritier, Vahid Asnafi,Kheira Beldjord,Marina Lafage,Norbert Ifrah, Hervé Dombret

BLOOD（2014）

引用 23|浏览48

暂无评分

摘要

Purpose: Pediatric-like protocols have yielded significant advances in younger adults with Ph-negative ALL. Nonetheless, the 5-year cumulative incidence of relapse was still estimated at 32% in the GRAALL-2003/2005 trials, approximately 25% of the relapses occurring after allogeneic stem cell transplantation (SCT). We report here on the outcome of these relapsing patients.

查看译文

关键词

acute lymphoblastic leukemia,philadelphia chromosome,first relapse

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要